Whitehawk Therapeutics (WHWK) Interest Coverage Ratio: 2020-2024
Historic Interest Coverage Ratio for Whitehawk Therapeutics (WHWK) over the last 4 years, with Sep 2024 value amounting to -352.97.
- Whitehawk Therapeutics' Interest Coverage Ratio fell 14.70% to -352.97 in Q3 2024 from the same period last year, while for Sep 2024 it was -313.85, marking a year-over-year decrease of 4.03%. This contributed to the annual value of -438.04 for FY2024, which is 40.67% down from last year.
- According to the latest figures from Q3 2024, Whitehawk Therapeutics' Interest Coverage Ratio is -352.97, which was down 31.37% from -268.69 recorded in Q2 2024.
- Over the past 5 years, Whitehawk Therapeutics' Interest Coverage Ratio peaked at 36.54 during Q4 2020, and registered a low of -556.12 during Q3 2021.
- Its 3-year average for Interest Coverage Ratio is -299.01, with a median of -307.74 in 2023.
- Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 4,682.26% in 2021, then skyrocketed by 53.38% in 2022.
- Over the past 5 years, Whitehawk Therapeutics' Interest Coverage Ratio (Quarterly) stood at 36.54 in 2020, then slumped by 865.58% to -279.74 in 2021, then rose by 2.97% to -271.44 in 2022, then decreased by 14.49% to -310.77 in 2023, then decreased by 14.70% to -352.97 in 2024.
- Its Interest Coverage Ratio stands at -352.97 for Q3 2024, versus -268.69 for Q2 2024 and -336.41 for Q1 2024.